Similar articles for PMID: 28974596

Year	Number of Results
1999	1
2007	1
2008	1
2010	2
2011	2
2012	4
2013	6
2014	10
2015	13
2016	16
2017	9
2018	13
2019	11
2020	10
2021	6
2022	5
2023	4
2024	1

1

New horizons in multimodality molecular imaging and novel radiotracers.

Barrington S, Blower P, Cook G. Barrington S, et al. Clin Med (Lond). 2017 Oct;17(5):444-448. doi: 10.7861/clinmedicine.17-5-444. Clin Med (Lond). 2017. PMID: 28974596 Free PMC article.

2

SPECT/CT, PET/CT and PET/MRI: oncologic and infectious applications and protocol considerations.

Voss SD. Voss SD. Pediatr Radiol. 2023 Jun;53(7):1443-1453. doi: 10.1007/s00247-023-05597-7. Epub 2023 Mar 11. Pediatr Radiol. 2023. PMID: 36899268 Review.

3

New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.

Evangelista L, Briganti A, Fanti S, Joniau S, Reske S, Schiavina R, Stief C, Thalmann GN, Picchio M. Evangelista L, et al. Eur Urol. 2016 Jul;70(1):161-175. doi: 10.1016/j.eururo.2016.01.029. Epub 2016 Feb 2. Eur Urol. 2016. PMID: 26850970 Review.

4

Discrepancies between positron emission tomography/magnetic resonance imaging and positron emission tomography/computed tomography in a cohort of oncological patients.

Oh G, O'Mahoney E, Jeavons S, Law P, Ngai S, McGill G, Yu C, Miles KA. Oh G, et al. J Med Imaging Radiat Oncol. 2020 Apr;64(2):204-210. doi: 10.1111/1754-9485.13000. Epub 2020 Feb 9. J Med Imaging Radiat Oncol. 2020. PMID: 32037655

5

Positron emission tomography-magnetic resonance imaging as a research tool in musculoskeletal conditions.

van den Wyngaert T, de Schepper S, Elvas F, Seyedinia SS, Beheshti M. van den Wyngaert T, et al. Q J Nucl Med Mol Imaging. 2022 Mar;66(1):15-30. doi: 10.23736/S1824-4785.22.03434-3. Epub 2022 Jan 10. Q J Nucl Med Mol Imaging. 2022. PMID: 35005878 Free article.

6

Applications of PET-Computed Tomography-Magnetic Resonance in the Management of Benign Musculoskeletal Disorders.

Yoder JS, Kogan F, Gold GE. Yoder JS, et al. PET Clin. 2019 Jan;14(1):1-15. doi: 10.1016/j.cpet.2018.08.001. PET Clin. 2019. PMID: 30420212 Free PMC article. Review.

7

Role of positron emission tomography in thyroid and neuroendocrine tumors.

Treglia G, Kroiss AS, Piccardo A, Lococo F, Santhanam P, Imperiale A. Treglia G, et al. Minerva Endocrinol. 2018 Sep;43(3):341-355. doi: 10.23736/S0391-1977.17.02742-0. Epub 2017 Sep 25. Minerva Endocrinol. 2018. PMID: 28949122 Review.

8

Future Challenges of Multimodality Imaging.

López-Mora DA, Lagos LA, Estorch M, Carrio I. López-Mora DA, et al. Recent Results Cancer Res. 2020;216:905-918. doi: 10.1007/978-3-030-42618-7_30. Recent Results Cancer Res. 2020. PMID: 32594412 Review.

9

Main applications of hybrid PET-MRI contrast agents: a review.

Kiani A, Esquevin A, Lepareur N, Bourguet P, Le Jeune F, Gauvrit J. Kiani A, et al. Contrast Media Mol Imaging. 2016 Mar-Apr;11(2):92-8. doi: 10.1002/cmmi.1674. Epub 2015 Dec 3. Contrast Media Mol Imaging. 2016. PMID: 26632007 Free article. Review.

10

Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.

Grueneisen J, Nagarajah J, Buchbender C, Hoffmann O, Schaarschmidt BM, Poeppel T, Forsting M, Quick HH, Umutlu L, Kinner S. Grueneisen J, et al. Invest Radiol. 2015 Aug;50(8):505-13. doi: 10.1097/RLI.0000000000000197. Invest Radiol. 2015. PMID: 26115367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year